India's Wockhardt jumps after drug aids liver transplant in US cancer patient
** Wockhardt WCKH.NS soars as much as 10% to 1,536.60
rupees
** Pharma co says its proprietary antibiotic Zaynich helped
73-year-old cancer patient in U.S. undergo liver transplant and
continue chemotherapy
** Stock gains 8.5% so far this month
** More than 1.3 mln shares traded, 2.6x the 30-day moving
avg
** WCKH adds 258.7% YTD
(Reporting by Meenakshi Maidas in Bengaluru)
((meenakshi.maidas@thomsonreuters.com;))
Recent news on Wockhardt
See all newsBrief: Wockhardt Says Customs Authority Imposes 50 Million Rupees Penalty And 100 Million Rupees Redemption Fine On Co
Brief: Wockhardt Limited June-Quarter Consol Net Profit 1.06 Billion Rupees
India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH
Brief: Wockhardt Says Indian Drug Regulator Grants Marketing Authorization To Co's Zaynich
India's Wockhardt hits 7‑month high after swinging to profit in fourth quarter